Sci 382(6667):7046 Coulter AA, Rebello CJ, Greenway FL (2018) Centrally acting agents for obesity: past, present, and future
A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
Michael Wittmer Personalized protocols based on your goals and labs Convenient telemedicine in all 50 states Related Resources Ipamorelin / CJC-1295 is a peptide blend designed to naturally stimulate growth hormone release without raising cortisol or prolactin levels
Without external damage visible, this is how it looks on the inside: By all means, I do not understand all these details 100% either, honestly I haven't met a person yet that does
What's in the KLOW Blend
SAM and SAH These markers help clarify methyl-donor capacity and inhibition of methyltransferase reactions